Award
University of Washington 4R33NS126626-03
Investigational WNT-pathway modulators for the treatment and prevention of drug-resistant seizures
Recipient
University of Washington
Award Amount
$373,489.00
Ceiling
$373,489.00
Awarded
August 18, 2025
Identifier
4R33NS126626-03
NIH awarded a grant to the University of Washington for research on WNT-pathway modulators to treat and prevent drug-resistant seizures, involving preclinical and pharmacokinetic studies.
Description
This is a funded NIH grant for research on investigational treatments for epilepsy, focusing on WNT-pathway modulators. The project involves preclinical studies, pharmacokinetics, and potential disease-modifying effects.